Qiagen stock faces market pressure due to recent NIH funding concerns, despite strong financials and a diverse product portfolio. Click to read why QGEN is a Hold.

Based on the one-year price targets offered by 15 analysts, the average target price for Qiagen NV (NYSE:QGEN) is $51.94 with a high estimate of $61.71 and a low estimate of $46.09. The average ...

A scientist in a lab coat using the latest medical equipment for nucleic acid purification. Qiagen NV (NYSE:QGEN) is a leading provider of sample and assay technologies for molecular diagnostics ...

PL VENLO, Netherlands (AP) — PL VENLO, Netherlands (AP) — Qiagen NV (QGEN) on Wednesday reported fourth-quarter net income of $88.3 million. On a per-share basis, the Pl Venlo, Netherlands ...

A stock is considered to be oversold if the RSI reading falls below 30. In trading on Monday, shares of Qiagen NV (Symbol: QGEN) entered into oversold territory, hitting an RSI reading of 29.8 ...

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

Qiagen (QGEN) announced that the FDA has cleared the QIAstat-Dx Gastrointestinal Panel 2 Mini B for clinical use. This marks Qiagen’s second ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.